Cetera Investment Advisers Bio Techne Corp Transaction History

Cetera Investment Advisers

$44.2 Billion
Q3 2024

A detailed history of Cetera Investment Advisers transactions in Bio Techne Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 20,744 shares of TECH stock, worth $1.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,744

Previous 23,513 11.78%

Holding current value

$1.52 Million

Previous $1.68 Million 1.6%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$70.96 - $82.35 $196,488 - $228,027	-2,769 Reduced 11.78%	20,744 $1.66 Million
Q2 2024 Aug 22, 2024	BUY	$62.12 - $84.15 $5,590 - $7,573	90 Added 0.38%	23,513 $1.68 Million
Q1 2024 May 24, 2024	BUY	$65.98 - $77.09 $1.18 Million - $1.38 Million	17,857 Added 320.82%	23,423 $1.65 Million
Q1 2024 May 14, 2024	SELL	$65.98 - $77.09 $289,190 - $337,885	-4,383 Reduced 44.05%	5,566 $391,000
Q4 2023 Feb 13, 2024	SELL	$52.83 - $78.22 $63,343 - $93,785	-1,199 Reduced 10.76%	9,949 $767,000
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $77,377 - $102,475	1,146 Added 11.46%	11,148 $758,000
Q2 2023 Aug 09, 2023	BUY	$73.76 - $85.98 $83,053 - $96,813	1,126 Added 12.69%	10,002 $816,000
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $5,801 - $7,016	81 Added 0.92%	8,876 $658,000
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $604,218 - $2.64 Million	7,490 Added 573.95%	8,795 $728,000
Q3 2022 Nov 10, 2022	SELL	$282.54 - $391.85 $38,707 - $53,683	-137 Reduced 9.5%	1,305 $371,000
Q2 2022 Aug 11, 2022	BUY	$322.67 - $449.65 $4,194 - $5,845	13 Added 0.91%	1,442 $500,000
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $20,523 - $28,291	-58 Reduced 3.9%	1,429 $619,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $635,416 - $731,408	-1,393 Reduced 48.37%	1,487 $769,000
Q3 2021 Nov 16, 2021	BUY	$444.87 - $538.88 $591,677 - $716,710	1,330 Added 85.81%	2,880 $1.4 Million
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $331,571 - $385,422	856 Added 123.34%	1,550 $698,000
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $269,629 - $352,227	-857 Reduced 55.25%	694 $265,000
Q4 2020 Feb 17, 2021	BUY	$246.9 - $321.87 $382,941 - $499,220	1,551 New	1,551 $493,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Bio Techne Corp Transaction History